Cargando…
Recombinant production of the lantibiotic nisin using Corynebacterium glutamicum in a two-step process
BACKGROUND: The bacteriocin nisin is naturally produced by Lactococcus lactis as an inactive prepeptide that is modified posttranslationally resulting in five (methyl-)lanthionine rings characteristic for class Ia bacteriocins. Export and proteolytic cleavage of the leader peptide results in release...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8760817/ https://www.ncbi.nlm.nih.gov/pubmed/35033086 http://dx.doi.org/10.1186/s12934-022-01739-y |
_version_ | 1784633402555629568 |
---|---|
author | Weixler, Dominik Berghoff, Max Ovchinnikov, Kirill V. Reich, Sebastian Goldbeck, Oliver Seibold, Gerd M. Wittmann, Christoph Bar, Nadav S. Eikmanns, Bernhard J. Diep, Dzung B. Riedel, Christian U. |
author_facet | Weixler, Dominik Berghoff, Max Ovchinnikov, Kirill V. Reich, Sebastian Goldbeck, Oliver Seibold, Gerd M. Wittmann, Christoph Bar, Nadav S. Eikmanns, Bernhard J. Diep, Dzung B. Riedel, Christian U. |
author_sort | Weixler, Dominik |
collection | PubMed |
description | BACKGROUND: The bacteriocin nisin is naturally produced by Lactococcus lactis as an inactive prepeptide that is modified posttranslationally resulting in five (methyl-)lanthionine rings characteristic for class Ia bacteriocins. Export and proteolytic cleavage of the leader peptide results in release of active nisin. By targeting the universal peptidoglycan precursor lipid II, nisin has a broad target spectrum including important human pathogens such as Listeria monocytogenes and methicillin-resistant Staphylococcus aureus strains. Industrial nisin production is currently performed using natural producer strains resulting in rather low product purity and limiting its application to preservation of dairy food products. RESULTS: We established heterologous nisin production using the biotechnological workhorse organism Corynebacterium glutamicum in a two-step process. We demonstrate successful biosynthesis and export of fully modified prenisin and its activation to mature nisin by a purified, soluble variant of the nisin protease NisP (sNisP) produced in Escherichia coli. Active nisin was detected by a L. lactis sensor strain with strictly nisin-dependent expression of the fluorescent protein mCherry. Following activation by sNisP, supernatants of the recombinant C. glutamicum producer strain cultivated in standard batch fermentations contained at least 1.25 mg/l active nisin. CONCLUSIONS: We demonstrate successful implementation of a two-step process for recombinant production of active nisin with C. glutamicum. This extends the spectrum of bioactive compounds that may be produced using C. glutamicum to a bacteriocin harboring complex posttranslational modifications. Our results provide a basis for further studies to optimize product yields, transfer production to sustainable substrates and purification of pharmaceutical grade nisin. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12934-022-01739-y. |
format | Online Article Text |
id | pubmed-8760817 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-87608172022-01-18 Recombinant production of the lantibiotic nisin using Corynebacterium glutamicum in a two-step process Weixler, Dominik Berghoff, Max Ovchinnikov, Kirill V. Reich, Sebastian Goldbeck, Oliver Seibold, Gerd M. Wittmann, Christoph Bar, Nadav S. Eikmanns, Bernhard J. Diep, Dzung B. Riedel, Christian U. Microb Cell Fact Research BACKGROUND: The bacteriocin nisin is naturally produced by Lactococcus lactis as an inactive prepeptide that is modified posttranslationally resulting in five (methyl-)lanthionine rings characteristic for class Ia bacteriocins. Export and proteolytic cleavage of the leader peptide results in release of active nisin. By targeting the universal peptidoglycan precursor lipid II, nisin has a broad target spectrum including important human pathogens such as Listeria monocytogenes and methicillin-resistant Staphylococcus aureus strains. Industrial nisin production is currently performed using natural producer strains resulting in rather low product purity and limiting its application to preservation of dairy food products. RESULTS: We established heterologous nisin production using the biotechnological workhorse organism Corynebacterium glutamicum in a two-step process. We demonstrate successful biosynthesis and export of fully modified prenisin and its activation to mature nisin by a purified, soluble variant of the nisin protease NisP (sNisP) produced in Escherichia coli. Active nisin was detected by a L. lactis sensor strain with strictly nisin-dependent expression of the fluorescent protein mCherry. Following activation by sNisP, supernatants of the recombinant C. glutamicum producer strain cultivated in standard batch fermentations contained at least 1.25 mg/l active nisin. CONCLUSIONS: We demonstrate successful implementation of a two-step process for recombinant production of active nisin with C. glutamicum. This extends the spectrum of bioactive compounds that may be produced using C. glutamicum to a bacteriocin harboring complex posttranslational modifications. Our results provide a basis for further studies to optimize product yields, transfer production to sustainable substrates and purification of pharmaceutical grade nisin. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12934-022-01739-y. BioMed Central 2022-01-15 /pmc/articles/PMC8760817/ /pubmed/35033086 http://dx.doi.org/10.1186/s12934-022-01739-y Text en © The Author(s) 2022, corrected publication 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Weixler, Dominik Berghoff, Max Ovchinnikov, Kirill V. Reich, Sebastian Goldbeck, Oliver Seibold, Gerd M. Wittmann, Christoph Bar, Nadav S. Eikmanns, Bernhard J. Diep, Dzung B. Riedel, Christian U. Recombinant production of the lantibiotic nisin using Corynebacterium glutamicum in a two-step process |
title | Recombinant production of the lantibiotic nisin using Corynebacterium glutamicum in a two-step process |
title_full | Recombinant production of the lantibiotic nisin using Corynebacterium glutamicum in a two-step process |
title_fullStr | Recombinant production of the lantibiotic nisin using Corynebacterium glutamicum in a two-step process |
title_full_unstemmed | Recombinant production of the lantibiotic nisin using Corynebacterium glutamicum in a two-step process |
title_short | Recombinant production of the lantibiotic nisin using Corynebacterium glutamicum in a two-step process |
title_sort | recombinant production of the lantibiotic nisin using corynebacterium glutamicum in a two-step process |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8760817/ https://www.ncbi.nlm.nih.gov/pubmed/35033086 http://dx.doi.org/10.1186/s12934-022-01739-y |
work_keys_str_mv | AT weixlerdominik recombinantproductionofthelantibioticnisinusingcorynebacteriumglutamicuminatwostepprocess AT berghoffmax recombinantproductionofthelantibioticnisinusingcorynebacteriumglutamicuminatwostepprocess AT ovchinnikovkirillv recombinantproductionofthelantibioticnisinusingcorynebacteriumglutamicuminatwostepprocess AT reichsebastian recombinantproductionofthelantibioticnisinusingcorynebacteriumglutamicuminatwostepprocess AT goldbeckoliver recombinantproductionofthelantibioticnisinusingcorynebacteriumglutamicuminatwostepprocess AT seiboldgerdm recombinantproductionofthelantibioticnisinusingcorynebacteriumglutamicuminatwostepprocess AT wittmannchristoph recombinantproductionofthelantibioticnisinusingcorynebacteriumglutamicuminatwostepprocess AT barnadavs recombinantproductionofthelantibioticnisinusingcorynebacteriumglutamicuminatwostepprocess AT eikmannsbernhardj recombinantproductionofthelantibioticnisinusingcorynebacteriumglutamicuminatwostepprocess AT diepdzungb recombinantproductionofthelantibioticnisinusingcorynebacteriumglutamicuminatwostepprocess AT riedelchristianu recombinantproductionofthelantibioticnisinusingcorynebacteriumglutamicuminatwostepprocess |